OncoCyte In the Media

10/8/2019 OncoCyte Eyeing More Tuck-ins As It Grows Cancer Diagnostic Portfolio Mergermarket
10/1/2019 Transitioning Emerging Companies into Commercial Powerhouses PharmaVOICE
9/24/2019OncoCyte Acquires Razor Genomics to Improve Management of Early-Stage Lung Cancer BioSpace
9/9/2019OncoCyte Resurrecting Lung Cancer Assay Once Marketed by Life TechnologiesGenomeWeb
9/5/2019OncoCyte Spells Out the Acquisition Plan for Razor GenomicsMD+DI
9/5/2019OncoCyte to Buy Early Lung Cancer Testing Company Razor GenomicsClinical OMICs
6/11/2019
 OncoCyte to be Added to the Russell 2000®, 3000® and Microcap Indexes Markets Insider
6/6/2019 OncoCyte (OCX) Announces Ronald Andrews will assume Role of CEO Street Insider
5/29/2019 OncoCyte Strengthens Senior Management Team With Two New Hires   Globe Newswire
5/21/2019 OncoCyte (OCX) Presents Positive Results from R&D Validation Study of DetermaVu at ATS  Street Insider
2/13/2019 Piper Jaffray Starts OncoCyte Corp (OCX) at Overweight  Street Insider
2/12/2019 OncoCyte Announces Closing of Public Offering of Common Stock  Globe Newswire
1/30/2019 OncoCyte Readies Lung Cancer Test for Launch, Previews New Platform Validation Data   GenomeWeb
1/29/2019 OncoCyte upgraded to buy at Janney on high hopes for lung cancer biopsy test   MarketWatch
1/3/2019 OncoCyte Announces Transition to Ion Torrent Next-Generation Sequencing Platform  Globe Newswire